Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.7566496055729431 | N/A |
Market Cap | $40.37M | N/A |
Shares Outstanding | 53.35M | N/A |
Employees | 12.00 | N/A |